Invention Grant
- Patent Title: Galactoside inhibitor of galectins
-
Application No.: US16539078Application Date: 2019-08-13
-
Publication No.: US10526360B2Publication Date: 2020-01-07
- Inventor: Thomas Brimert , Richard Johnsson , Hakon Leffler , Ulf Nilsson , Fredrik Zetterberg
- Applicant: Galecto Biotech AB
- Applicant Address: DE Copenhagen
- Assignee: Galecto Biotech AB
- Current Assignee: Galecto Biotech AB
- Current Assignee Address: DE Copenhagen
- Agency: Maier & Maier, PLLC
- Priority: EP15153316 20150130; EP15192291 20151030
- Main IPC: C07H17/02
- IPC: C07H17/02 ; C07H19/056 ; C07H15/203 ; C07H15/207
Abstract:
An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
Public/Granted literature
- US20190359643A1 NOVEL GALACTOSIDE INHIBITOR OF GALECTINS Public/Granted day:2019-11-28
Information query
